Rogaine extra strength and Ketoconazole drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Rogaine extra strength (minoxidil) and Ketoconazole (ketoconazole). Common drug interactions include pain of skin among females and overdose among males.
The phase IV clinical study analyzes what interactions people have when they take Rogaine extra strength and Ketoconazole. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.
What is Rogaine extra strength?
Rogaine extra strength has active ingredients of minoxidil. It is often used in hair loss. eHealthMe is studying from 12,027 Rogaine extra strength users. Check the latest studies of Rogaine extra strength.
What is Ketoconazole?
Ketoconazole has active ingredients of ketoconazole. It is often used in fungal infection. eHealthMe is studying from 16,014 Ketoconazole users. Check the latest studies of Ketoconazole.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
17 people who take Rogaine extra strength and Ketoconazole together, and have interactions are studied.

What are the common drug interactions of Rogaine Extra Strength and Ketoconazole, by gender? *:
female:
- Pain of skin
- Pruritus (severe itching of the skin)
- Skin burning sensation
- Skin irritation
- Application site pruritus (application site severe itching of the skin)
- Blood potassium decreased
- Dizziness
- Loss of consciousness
- Drug ineffective
- Hair disorder
male:
- Overdose
- Pruritus (severe itching of the skin)
- Left ventricular hypertrophy (the thickening of the myocardium (muscle) of the left ventricle of the heart)
- Therapeutic response unexpected
- Application site pain
- Application site rash
- Burning sensation
- Drug ineffective
What are the common drug interactions of Rogaine Extra Strength and Ketoconazole, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Pruritus (severe itching of the skin)
30-39:
n/a
40-49:
- Application site pain
50-59:
- Hair disorder
- Overdose
60+:
- Drug ineffective
- Pruritus (severe itching of the skin)
- Burning sensation
- Pain of skin
- Skin burning sensation
- Skin irritation
- Application site pruritus (application site severe itching of the skin)
- Blood potassium decreased
- Dizziness
- Loss of consciousness
What are the existing conditions these people have? *
- High Blood Cholesterol: 3 people, 17.65%
- Hair Growth Abnormal: 3 people, 17.65%
- Seborrheic Dermatitis (a common, inflammatory skin condition that causes flaky, white to yellowish scales to form on oily areas such as the scalp): 2 people, 11.76%
- Androgenetic Alopecia (common form of hair loss): 1 person, 5.88%
- Asthma: 1 person, 5.88%
- Barrett's Oesophagus (barrett's oesophagus is a disorder in which the lining of the oesophagus (the tube that carries food from the throat to the stomach) is damaged by stomach acid and changed to a lining similar to that of the stomach): 1 person, 5.88%
- Chest Pain: 1 person, 5.88%
- Depression: 1 person, 5.88%
- Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it): 1 person, 5.88%
- Diabetes: 1 person, 5.88%
* Approximation only. Some reports may have incomplete information.
Do you take Rogaine extra strength and Ketoconazole?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Rogaine extra strength (12,027 reports)
- Ketoconazole (16,014 reports)
Browse all drug interactions of Rogaine extra strength and Ketoconazole:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Rogaine extra strength:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Ketoconazole:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Rogaine extra strength and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ketoconazole and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Dubrey SW, VanGriethuysen J, Edwards CM, "A hairy fall: syncope resulting from topical application of minoxidil", BMJ case reports, 2015 Sep .
- Dubrey SW, VanGriethuysen J, Edwards CM, "A hairy fall: syncope resulting from topical application of minoxidil", BMJ case reports, 2015 Sep .
How the study uses the data?
The study uses data from the FDA. It is based on minoxidil and ketoconazole (the active ingredients of Rogaine extra strength and Ketoconazole, respectively), and Rogaine extra strength and Ketoconazole (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Singulair cause Vital Capacity Decreased? - now
- Aggression and drugs of ingredients of acamprosate calcium - 5 seconds ago
- Zopiclone and Oxycodone drug interactions for women aged 50-59 - 7 seconds ago
- Lisinopril and Vaginal Prolapse for Women aged 60+ - 8 seconds ago
- Could Modafinil cause Sleep Talking? - 10 seconds ago
- Citalopram Hydrobromide and Foradil drug interactions for women aged 60+ - 11 seconds ago
- Drug interactions of Topamax and Maxair - 13 seconds ago
- Lopurin and Pepcid drug interactions for men aged 50-59 - 14 seconds ago
- Supradyn and Dysstasia for Women aged 60+ - 18 seconds ago
- Nystop and Humalog drug interactions for women aged 50-59 - 19 seconds ago